Clinical outcome of SARS-CoV-2 infection in breast and ovarian cancer patients who underwent antiestrogenic therapy

Affiliations

• ¹ Department of Pharmaceutical and Pharmacological Sciences, Università degli Studi di Padova, Padova, Italy; VIMM-Veneto Institute of Molecular Medicine, Fondazione per la Ricerca Biomedica Avanzata, Padova, Italy; Institute of Oncology Research (IOR), Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
• ² Veneto Tumour Registry, Azienda Zero, Padova, Italy.
• ³ Department of Pharmaceutical and Pharmacological Sciences, Università degli Studi di Padova, Padova, Italy.
• ⁴ Department of Oncological and Gastroenterological Sciences-Urology Unit, Azienda Ospedaliera di Padova, Padova, Italy.
• ⁵ Veneto Tumour Registry, Azienda Zero, Padova, Italy; Department of Medicine, Università degli Studi di Padova, Padova, Italy. Electronic address: [email protected].
• ⁶ Institute of Oncology Research (IOR), Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Università della Svizzera Italiana, Lugano, Switzerland. Electronic address: [email protected].